Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

Share Price is delayed by 15 minutes
Get Live Data
816.00    8.00 (0.99%)
Bid:
815.00
Ask:
816.00
Spread: 1.00 (0.123%)
Market Cap: £1.13b
SVS Live PriceLast checked at - London Stock Exchange

Intraday Savills Share Chart

Interim Management Statement

17 Nov 2009 07:00

RNS Number : 5968C
Savills PLC
17 November 2009
Β 

ο»Ώ

17 November 2009

SAVILLS PLC

("Savills" or "the Company")

Interim Management Statement

Savills plc, the international real estate advisor, publishes the following Interim Management Statement (IMS) for the period from July to date.

Summary and OverviewΒ 

Since June our UK Residential and Asia Pacific businesses have performed strongly whilst our European business has continued to face challenging market conditions. Overall our businesses have performed creditably, and we have continued to reduce costs whilst maintaining the operating capacity of our transaction teams around the world to take advantage of any improvement in market conditions. The balance sheet remains strong and we continue to anticipate that performance for the year will be consistent with our expectations.

Transactional Advice

Commercial

In theΒ UK, investment market activity has focused on properties with long leases in prime locations with high quality tenants, for which there is demand from buyers globally. The limited supply of these assets means that transactional volumes remain significantly reduced and high investor interest has compressed investment yields accordingly. For the majority of the period, there has been little or no investment activity beyond this prime asset type, although there are some recent signs that investors are starting to look at the next tier down. Occupational agency markets have continued to be challenging although there has been some improvement in theΒ LondonΒ office market in particular.

In Asia Pacific, particularly Hong Kong andΒ China, the transaction business improved in the third quarter driven by strong demand from investors in the region. Lately there are indications that this lending-based rally may not be sustainable in the medium term.

In Continental Europe there continued to be little investment activity, although recently there has been an increase in investor interest in markets such asΒ ParisΒ where international investors typically show interest early in recovering markets. In contrast our Irish business has continued to be adversely affected by the economic situation in that country. Overall, the Continental European businesses continue to be challenged by the relative lack of transaction activity, the cost and time taken to achieve material cost savings in many European jurisdictions and the continued adverse effect of currency translation.

In theΒ United StatesΒ the real estate investment market has remained largely inactive. SavillsΒ New York, ourΒ USΒ capital markets business, has completed a number of transactions and performed in accordance with our expectations.

Residential

Our UK Residential Agency business has continued to perform strongly since June driven by recovery in the prime markets ofΒ LondonΒ and the South East. There are some signs of calming since the end of September alongside the seasonal slowdown in new instructions. This, together with the prospect of a general election and increased taxation in the second quarter of 2010, indicates that we should be cautious about further improvements in the market in the short term, but can take comfort from its improved stability into the fourth quarter of this year.Β 

Consultancy

The range of our consultancy services in theΒ UKΒ in particular has continued to provide some stability to overall revenues with strong performances in areas such as Housing ConsultancyΒ partially compensating for other services for which the markets remain challenging. Our Valuation practices in the UK and Continental Europe have continued to experience significant volumes driven by the banks' reviews of their loan portfolios, but competitive pressure has resulted in continuation of the significant fee discounting we experienced in the first half of the year. In Asia Pacific a strong third quarter for transactions also improved the performance of ourΒ Hong Kong and mainland Chinese Valuation teams and other consultancy businesses.Β 

Property Management

UK Property Management has continued to perform strongly since the half year benefiting from new mandates won in the last twelve months and a continued focus on efficiency of operations. In the principal Asia Pacific markets of Hong Kong andΒ ChinaΒ the business has continued to grow in line with our expectations.

Financial Services and Fund Management

Revenue at Savills Private Finance has stabilised over the period since June with some signs of improvement in theΒ UKΒ mortgage market, albeit off a very low base. This, together with the cost cutting carried out earlier in the year has ensured that the business has traded in line with our expectations.

Revenue at Cordea Savills remains in line with expectations with reduced fees primarily as a result of lower transaction volumes. We have continued to see significant net inflows into the core open-ended funds, and positive developments in the outstanding restructuring of some of our closed-end opportunistic funds.

Effect of Cost Savings

The Group has benefited from an increase in cost savings during the period which are tracking ahead of our expectations at over Β£60m for the year compared with the 2008 cost base. In difficult market conditions, this has enabled us to continue to invest in our business by maintaining much of our global capacity in transaction advisory services and selectively recruiting high quality talent without adversely affecting our performance expectations for the year as a whole.Β 

For further information, contact:

Savills 020 7409 8844

Jeremy Helsby, Group Chief ExecutiveΒ 

Simon Shaw, Group Chief Financial Officer

Tulchan Communications 020 7353 4200

John Sunnucks

Forward looking statements

Certain information included within this statement is forward-looking and by its nature involve risks and uncertainties because it relates to events and depends on circumstances that will occur in future.Β 

Forward-looking statements include, without limitation, projections relating to results of operations and financial conditions, market estimates, the Company's plans and objectives for future operations, including future revenues, financial plans and expected expenditures and divestments.Β 

There are a number of factors which could cause actual results and developments to differ materially from those expressed or implied by these forward looking statements including a number of factors outside the Company's control. All forward-looking statements in this report are based upon information known to theΒ Company on the date of this IMS. The Company gives no undertaking to update forward looking statements whether as a result of new information, future events or otherwise.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSEAXFKFDDNFFE
Date   Source Headline
2nd Dec 202410:00 amRNSTotal Voting Rights
26th Nov 20243:34 pmRNSHolding(s) in Company
22nd Nov 20242:00 pmRNSAdditional Listing
15th Nov 20242:58 pmRNSHolding(s) in Company
14th Nov 20241:53 pmRNSHolding(s) in Company
13th Nov 20241:47 pmRNSHolding(s) in Company
12th Nov 20242:51 pmRNSDirector/PDMR Shareholding
12th Nov 20242:48 pmRNSHolding(s) in Company
11th Nov 20242:25 pmRNSHolding(s) in Company
1st Nov 202411:00 amRNSTotal Voting Rights
14th Oct 20249:52 amRNSDirector/PDMR Shareholding
4th Oct 20242:00 pmRNSAdditional Listing
1st Oct 202411:00 amRNSTotal Voting Rights
18th Sep 20242:43 pmRNSDirector Declaration
16th Sep 20243:50 pmRNSDirector Declaration
12th Sep 20241:47 pmRNSDirector/PDMR Shareholding
2nd Sep 202411:00 amRNSTotal Voting Rights
29th Aug 20242:24 pmRNSDirector/PDMR Shareholding
15th Aug 202411:00 amRNSBlock listing Interim Review
13th Aug 20243:17 pmRNSDirector/PDMR Shareholding
8th Aug 20247:00 amRNSHalf-year Report
1st Aug 202411:00 amRNSTotal Voting Rights
30th Jul 20242:11 pmRNSHolding(s) in Company
22nd Jul 20242:36 pmRNSBlock listing Interim Review
11th Jul 20244:26 pmRNSDirector/PDMR Shareholding
1st Jul 20249:27 amRNSTotal Voting Rights
20th Jun 202410:36 amRNSDirector/PDMR Shareholding
13th Jun 20241:37 pmRNSDirector/PDMR Shareholding
11th Jun 20244:42 pmRNSDirector/PDMR Shareholding
7th Jun 20244:01 pmRNSDirector/PDMR Shareholding
4th Jun 20242:43 pmRNSDirector/PDMR Shareholding
3rd Jun 202411:00 amRNSTotal Voting Rights
23rd May 20242:21 pmRNSDirector/PDMR Shareholding
17th May 20243:44 pmRNSDirector/PDMR Shareholding
15th May 20243:06 pmRNSResult of AGM
15th May 202410:02 amRNSAGM Statement
14th May 20248:00 amRNSDirector/PDMR Shareholding
2nd May 20248:28 amRNSTotal Voting Rights
26th Apr 20242:13 pmRNSDirector/PDMR Shareholding
26th Apr 202411:21 amRNSDirector Declaration
15th Apr 20243:42 pmRNSDirector/PDMR Shareholding
12th Apr 20245:12 pmRNSDirector/PDMR Shareholding
8th Apr 20243:47 pmRNSAnnual Report and AGM Notice
21st Mar 20248:17 amRNSDirector/PDMR Shareholding
19th Mar 20245:11 pmRNSHolding(s) in Company
14th Mar 20247:00 amRNSNon-Executive Director Appointment
14th Mar 20247:00 amRNSFinal Results
13th Mar 20241:37 pmRNSDirector/PDMR Shareholding
15th Feb 202410:00 amRNSBlock listing Interim Review
13th Feb 20246:07 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.